Quantbot Technologies LP Argenx Se Transaction History

Quantbot Technologies LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $1.15 Million - $1.58 Million	-4,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$272.01 - $353.03 $1.22 Million - $1.59 Million	4,500 New	4,500 $1.58 Million
Q1 2021 May 14, 2021	SELL	$268.3 - $380.31 $26,830 - $38,031	-100 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$248.13 - $308.36 $24,813 - $30,836	-100 Reduced 50.0%	100 $29,000
Q3 2020 Nov 16, 2020	BUY	$215.51 - $272.51 $43,102 - $54,502	200 New	200 $52,000
Q4 2019 Feb 10, 2020	SELL	$106.59 - $164.21 $10,659 - $16,421	-100 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$113.31 - $150.51 $11,331 - $15,051	100 New	100 $11,000
Q3 2018 Nov 13, 2018	SELL	$75.5 - $96.63 $130,992 - $167,653	-1,735 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$74.84 - $100.16 $74 - $100	-1 Reduced 0.06%	1,735 $143,000
Q1 2018 May 11, 2018	SELL	$56.95 - $85.19 $28,987 - $43,361	-509 Reduced 22.67%	1,736 $139,000
Q4 2017 Feb 12, 2018	BUY	$22.57 - $63.56 $50,669 - $142,692	2,245	2,245 $141,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.9B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.